Functional and structural decline in the neuromuscular system with aging has been recognized as a cause of impairment in physical performance and loss of independence in the elderly. Alterations in spinal cord motor neurones and at the neuromuscular junction have been identified as evidence of denervation in skeletal muscles from aging mammals, including humans. However, the reciprocal influences of neurones on gene expression in muscle and of muscle on age-related neurodegeneration are poorly understood, and, as a result, interventions aimed at delaying or preventing degeneration of the neural component in aging muscle have been largely unsuccessful. The present article discusses the evidence for neural influence on age-related impairments of skeletal muscle, including a role in excitation-contraction uncoupling. The role of nerves in regulating the trophic actions of insulin-like growth factor-1 (IGF-1) and other neurotrophic factors is considered as a novel influence on the effects of aging on the neuromuscular junction. A better understanding of nerve-muscle interactions will allow for more rational interventions in the aging neuromuscular system.
Introduction
Age-related decline in the neuromuscular system has been recognized as a cause of impairment in physical performance and loss of independence in the elderly. Epidemiological data support the concept that these changes are associated with an increased risk of morbidity, disability and mortality in the elderly (Winograd et al ., 1991; Baumgartner et al ., 1998) . Some studies, particularly in the last decade, have focused on the mechanisms underlying neuromuscular impairments in old age, hoping that this may lead to novel therapies. Several aspects have been investigated; the phenomenon known as excitation-contraction uncoupling Wang et al ., 2002) leading to a decline in muscle-specific force (force normalized to crosssectional area) (González et al ., 2000) ; loss in muscle mass associated with decrease in the number of muscle fibres as well as fibre atrophy (Lexell, 1995; Dutta, 1997) ; changes in fibre type (Larsson et al ., 1991; Frontera et al ., 2000) ; decline in muscle power associated with decreased maximal isometric force and slower sliding speed of actin on myosin (Brooks & Faulkner, 1994; Hook et al ., 1999) and impaired recovery after eccentric contraction (Faulkner et al ., 1993) . Identifying the triggers of these changes remains elusive. However, some suggestions have been made. These include decreased muscle loading (Tseng et al ., 1995) , oxidative damage (Weindruch, 1995) , age-dependent decrease in insulin-like growth factor-1 (IGF-1), expression or tissue sensitivity Owino et al ., 2001) , and decline in satellite cell proliferation (Decary et al ., 1997) .
An important issue which has not been addressed in these discussions of age-related changes in nerve and muscle is that interaction between these two interdependent tissues is crucial to the capacity of both partners to survive and function adequately throughout life. Thus, muscle atrophy and weakness may result from primary neural or muscular aetiological factors, or a combination of both. The primary emphasis of the present review is on two key aspects of this relationship: the evidence for neural aetiological factors and the role of IGF-1, including the contribution of neural influences, on the decline in neuromuscular function with aging.
Neural influences on aging skeletal muscle
Aging skeletal muscle exhibits alterations in fibre innervation. Several groups have reported skeletal muscle denervation and re-innervation, motor unit remodelling or loss in aging rodents or humans (Hashizume et al ., 1988; Kanda & Hashizume, 1989 , 1992 Einsiedel & Luff, 1992; Doherty et al ., 1993; Johnson et al ., 1995; Zhang et al ., 1996) . Motor unit remodelling leads to changes in fibre-type composition (Pette & Staron, 2001) . During development, muscle fibre type phenotype is determined by interactions with subpopulations of ventral spinal cord motor neurones that activate contraction at different rates, ranging from 10 (slow fibres) to 100 (fast-fatigue resistant) or 150 Hz (fast-fatigue sensitive) (Buller et al ., 1960a (Buller et al ., , 1960b Greensmith & Vrbova, 1996) . Age-related remodelling of motor units appears to involve denervation of fast muscle fibres with re-innervation by axonal sprouting from slow fibres (Lexell, 1995; Larsson, 1995; Kadhiresan et al ., 1996; Frey et al ., 2000) . When denervation outpaces re-innervation a population of muscle fibres becomes atrophic and functionally excluded. Although denervation contributes to skeletal muscle atrophy and functional impairment with aging (Larsson & Ansved, 1995) , the time course of muscle denervation, and its prevalence in human and animal models of aging, remain to be determined. A recent report analyses the contribution of denervation to deficits in specific force in skeletal muscle in 27-29-month (old) compared with 3-month (young) rats (Urbancheck et al ., 2001) . The combination of contraction force recordings together with muscle immunostaining for NCAM protein, a marker of fibre denervation (Andersson et al ., 1993; Gosztonyi et al ., 2001) , has shown a significantly higher number of denervated fibres in old rats. It has also been shown that the area of denervated fibres, detected by positive staining with NCAM antibodies, accounts for a significant fraction of the decline in specific force (Urbancheck et al ., 2001) .
Recovery from denervation implies nerve sprouting and reinnervation by the same or neighbouring motor units. Different methods of inducing transient nerve injury and recovery have been employed with contrasting results. A slower regeneration and re-innervation in aged compared to young motor endplates has been recorded in response to crush injury of the peripheral nerve (Kawabuchi et al ., 2001) . The difference in the time needed to recover from nerve injury has been attributed to a transient failure in the spatiotemporal relationship between Schwann cells, axons and the post-synaptic acetylcholine receptor regions during re-innervation in aged rats (Kawabuchi et al ., 2001) , i.e. nerve-muscle interactions contribute significantly to age-related impairments in recovery after nerve injury. However, in apparent contrast, a comparable capacity for regeneration has been shown in muscles from very old compared to young rats ). Effects of age on muscle regeneration were studied by injecting the local anaesthetic, bupivacaine, in fast-twitch muscles. This agent induced similar muscle fibre damage and reduction in the mean tetanic tension in fasttwitch muscles from young adult (4 months) and old (32 and 34 months) rats. In a different approach, the same authors investigated muscle regeneration using heterochronic transplantation of nerve-intact extensor digitorum longus (EDL), a fast twitch muscle. EDL muscles from 4-month or 32-monthold rats were cross-transplanted in place of the same muscle in 4-month-old-hosts. As a control, contralateral muscles were autotransplanted back into the donors. After 60 days, the old-into-young muscle transplants regenerated as well as the young-into-young autotransplants. Lack of nerve damage provided favourable conditions for muscle regeneration, together with an age-related effect of the local environment on the transplants . As evidence of the importance of neural factors in nerve regeneration, the same group reported that when axons are allowed to regenerate in an endoneurial environment, there is no evidence of age-related impairment in muscle re-innervation (Cederna et al ., 2001) . In summary, although old muscle is capable of regeneration similar to that of young muscle, the presence of an intact nerve supply appears to be critical to recovery, together with less clearly defined factors associated with the local environment. One of the local factors which we believe to be vital for the protection of nerve and muscle from age-related degeneration is insulin-like growth factor-1 (IGF-1) secretion and signalling (see below).
Effects of age on the neuromuscular junction
Neural alterations occur at different locations, spanning from the spinal cord motor neurone to the neuromuscular junction. Neural alterations occur at the ventral spinal cord motor neurone, peripheral nerve and neuromuscular junction in aging mammals. Age-related changes in the neuronal soma size (Liu et al ., 1996; Kanda & Hashizume, 1998) and number (Hashizume et al ., 1988; Zhang et al ., 1996; Jacob, 1998) in the spinal cord have been reported. Age-related changes in peripheral nerve have been documented in tibialis nerves of mice aged 6 -33 months (Ceballos et al ., 1999) including accumulation of collagen in the perineurium and lipid droplets in the perineurial cells, together with an increase in the number of macrophages and mast cells. Schwann cells associated with myelinated fibres (MF) decrease slightly in number, in parallel with an increase of the internodal length from 6 to 12 months, but then increase in number in older nerves in parallel with the greater incidence of demyelination and remyelination. The reported unmyelinated axon (UA) to myelinated fibre (UA/ MF) ratio is about 2 until 12 months, decreasing to 1.6 by 27 months. In older mice, the loss of nerve fibres involves UA (50% loss at 27-33 months) more markedly than MF (35%). In aged nerves, wide incisures and infolded or outfolded myelin loops are frequent, resulting in an increased irregularity in the morphology of fibres along the internodes (Ceballos et al ., 1999) . In summary, several features of degeneration appear progressively in adult mouse nerves (12-20 months), whereas general nerve disorganization and marked fibre loss occurs from 20 months upwards (Ceballos et al ., 1999) . The deterioration of myelin sheaths during aging may be due to a decrease in the expression of the major myelin proteins (P0, PMP22, MBP). Axonal atrophy, frequently seen in aged nerves, may be explained by a reduction in the expression and axonal transport of cytoskeletal proteins in the peripheral nerve (Verdu et al ., 2000) . The incidence and severity of the age-related peripheral nerve changes seems to depend on the animal's genetic background. Thus, histological examination conducted on isolated sciatic nerves and brachial plexuses revealed axonal degeneration and remyelination which was more pronounced in B6C3F1 and C3H than in C57BL mice (Tabata et al ., 2000) . Impairment in nerve regeneration in animals and humans has been correlated with diminished anterograde and retrograde axonal transport (Kerezoudi & Thomas, 1999) . Retardation in the slow axonal transport of cytoskeletal elements during maturation and aging has been reported (McQuarrie et al ., 1989) . The reduced axonal transport could account for the inability of the motor neurone in old mice to expand the field of innervation in response to partial denervation (Jacob & Robbins, 1990 ).
Plasticity at the neuromuscular junction
Alterations of the neuromuscular junction have been reported in association with aging. 'Instability of neuromuscular junctions' has been suggested (Balice-Gordon, 1997). The process of neuromuscular synapse formation and activity-dependent editing of neuromuscular synaptic connections are better understood (Personius & Balice-Gordon, 2000) than the events leading to denervation in aging mammals. Apparently, after synapse formation, the terminals of the same axon, described as a 'cartel', exhibit heterogeneity in terms of acetylcholine release, which may contribute to nerve terminal selection in the developmental transition from innervation of each muscle fibre by multiple nerve endings to the adult one-on-one pattern. It has also been demonstrated that activity plays a crucial role in synapse elimination during this period (for a review see Personius & Balice-Gordon, 2000) . These concepts prompt the interesting hypothesis that a similar mechanism for neuromuscular synapse elimination is retained in senescent mammals. The level of physical activity among the elderly is highly variable and is considered of importance for successful neuromuscular function. The role of activity in neuromuscular synapse integrity at old age has not yet been explored. However, synaptic terminals occupying motor endplates in adult rats, when made electrically silent by the sodium channel blocker tetrodotoxin or by the acetylcholine receptor blocker α -bungarotoxin, were frequently displaced by regenerating axons that were also both inactive and synaptically ineffective. This study concludes that neither evoked nor spontaneous activation of acetylcholine receptors is required for competitive reoccupation of neuromuscular synaptic sites by regenerating motor axons in adult rats (Costanzo et al ., 2000) .
Experimental denervation of skeletal muscle leads to a series of changes in skeletal muscles from aging rodents, such as reorientation of costameres (rib-like structures formed by dystrophin and β -dystroglycan) (Bezakova & Lomo, 2001 ), proliferation of triadic membranes (Salvatori et al ., 1988) , decrease in charge movement (functional expression of the dihydropyridine receptor voltage sensor) and alterations in the sarcoplasmic reticulum calcium release channel (Delbono, 1992; Delbono & Stefani, 1993; Delbono & Chu, 1995; Delbono et al ., 1997; Wang et al ., 2000) . We hypothesize that age-related denervation (see above) may induce these structural and functional changes in mammalian muscle, including in humans. The molecular substrate for these alterations is only partially understood. Costameric proteins transmit mechanical lateral forces and provide structural integrity in contracting mechanically loaded muscle fibres (Straub & Campbell, 1997) . Muscle activity and muscle agrin, the latter at a concentration two orders of magnitude lower than the effective concentration of neural agrin, regulate the organization of cytoskeletal proteins in skeletal muscle fibres (Bezakova & Lomo, 2001 ). It would be interesting to explore these molecular changes in aging muscle and examine the potential beneficial effect of muscle agrin on costamere structure and force development.
The studies reported above strongly implicate neural alterations in the onset and progression of the age-related decline in skeletal muscle function. Therefore, interventions focused on spinal cord motor neurones, their axons and associated nonneuronal cells, and the neuromuscular junction may slow down or even reverse age-related impairments of skeletal muscle.
Excitation-contraction uncoupling
Skeletal muscle contraction is initiated by action potentials generated in the motor neurone and conducted via its axons, culminating in release of acetylcholine at the motor-end plate. Acetylcholine binds to nicotinic acetylcholine receptors, leading to an increase in sodium and potassium conductance in the endplate membrane. End-plate potentials at the muscle membrane lead to generation of action potentials and their conduction to the sarcolemmal infoldings (T-tubules). The transduction of changes in sarcolemmal potential into elevations in intracellular calcium concentration is a key event that precedes muscle contraction. Electromechanical transduction in the muscle cell requires the participation of the dihydropyridine receptor (DHPR) (Schneider & Chandler, 1973) release from an intracellular store (SR) through ryanodinesensitive calcium channels (RyR1) into the sarcoplasm. The functional consequence of reduction in the number, function or interaction of these receptors is a reduction in the amount of intracellular calcium mobilization and in the development of force . Calcium is bound to troponin C, leading to formation of cross-linkages between actin and myosin and sliding of thin on thick filaments, producing force (Loeser & Delbono, 1999) . This whole process linking nerve stimulation to muscle contraction constitutes excitationcontraction coupling and is, we believe, a key focus of ageassociated impairment. Aging muscle fibres exhibit less specific force and similar endurance and recovery from fatigue than those from youngadult or middle-aged animals (González et al ., 2000; González & Delbono, 2001a , 2001b . Uncoupling of the machinery of excitation-contraction is one of the major factors contributing to the age-dependent decline in force-generating capacity of individual cells. Whether excitation-contraction uncoupling results from alterations in neural control of muscle gene expression is not known at the present time. However, a series of studies have supported this concept: for example, denervation results in a significant decrease in DHPR functional expression and alterations in excitation-contraction coupling in skeletal muscle from adult rats (Delbono, 1992) ; nerve crush leads to reduction in the levels of mRNA encoding DHPR subunits and RyR1 in muscle (Ray et al ., 1995) ; also, there are indications that both DHPR and RyR1 expression are dependent on skeletal muscle innervation (Kyselovic et al ., 1994; Pereon et al ., 1997b) ; during development, DHPR mRNA levels change in relation with fibre innervation (Chaudari & Beam, 1993) ; myotube depolarization triggers the appearance of (+)-[ 3 H]PN 200 -110 binding sites (Pauwels et al ., 1987) ; and, finally, exercise and chronic stimulation in vivo increase the expression of DHPR in homogenates of soleus and EDL muscles (Saborido et al ., 1995; Pereon et al ., 1997a) . These studies support the concept that fibre-type composition, DHPR and RyR1, and excitationcontraction coupling depend on nerve stimulation and muscle activity. In summary, we are therefore starting to understand the mechanisms by which nerve stimulation of muscle activity influences muscle phenotype and the specific sarcolemmalnuclear signalling pathways involved in muscle gene expression at different ages. Increasing evidence points to a decline in neural influence on skeletal muscle at later ages, leading to changes in muscle composition which together result in excitation-contraction uncoupling.
Trophic factors regulation of spinal cord motor neurone structure and function
Classical neurotrophic theory (Davies, 1996) describes a wellestablished role for target-derived neurotrophic factors, including the archetypal neurotrophin, NGF, in the regulation of survival of developing neurones in the peripheral and central nervous systems. More recent studies point to a continued role for target-derived trophic factors in the plasticity of adult and aged neurones (Cowen & Gavazzi, 1998; Bergman et al ., 2000) . Although there is little direct evidence for an involvement in aging, a series of studies suggest a role for neurotrophins at least in the adult neuromuscular system. Trophic factors have been implicated in neuronal and synaptic plasticity at the adult neuromuscular junction. However, in this case, neural activity appears to be a significant contributor to the trophic interactions between nerve and muscle. For example, neurotrophins regulate the development of synaptic function (Lohof et al ., 1993) and a recent formulation of the neurotrophin hypothesis proposes that neurotrophins participate in activity-induced modification of synaptic transmission (Schinder & Poo, 2000) . Potentiation of synaptic efficacy by brain-derived neurotrophic factor is facilitated by presynaptic depolarization at developing neuromuscular synapses (Boulanger & Poo, 1999) . Using a model system of nerve-muscle coculture in which neurotrophin-4 (NT-4) is overexpressed in a subpopulation of post-synaptic myocytes, presynaptic potentiation was shown to be restricted to synapses on myocytes overexpressing NT-4. Nearby synapses formed by the same neurone on control myocytes were not affected (Wang et al ., 1998) . Furthermore, the production of endogenous NT-4 messenger RNA in rat skeletal muscle was regulated by muscle activity; the amounts of NT-4 messenger RNA decreased after blockade of neuromuscular transmission with α -bungarotoxin, and increased during postnatal development, as well as following electrical stimulation. Finally, it has been suggested that NT-4 may mediate the effects of exercise and electrical stimulation on neuromuscular performance (Funakoshi et al ., 1995) . Thus, to summarize, muscle-derived NT-4 appears to act as an activity-dependent, muscle-derived neurotrophic signal for growth and remodelling of the adult neuromuscular junction. Investigation of this complex, interactive role for neural activity in the regulation of nerve-target interactions has not been extended to the aging neuromuscular junction. However, evidence supporting a role for neurotrophin signalling in agerelated degeneration of the cutaneous innervation has come from the observation of a close correlation between altered ligand-receptor expression(s) and axonal/terminal aberrations in senescence (Bergman et al ., 2000) . An age-related decrease in target neurotrophin expression, notably NT3 and NT4, correlated with site-specific loss of sensory terminals combined with an aberrant growth of regenerating/sprouting axons into new target fields. Aging of the cutaneous innervation, manifested in degenerative and regenerative events, seems to be strongly associated with changes in neurotrophic interactions between sensory neurones and target tissues (Bergman et al ., 2000) . However, at this stage, there is no information about the possible contribution of neural activity to this example of age-related nerve-target alterations. Clearly therefore it will be worthwhile to explore more specifically the role of neural activity and neurotrophin signalling in relation to age-changes in nervemuscle structure and function in the hope that this will lead to novel targets for therapy.
The role of IGF-1 and the related binding proteins in neural control of skeletal muscle excitation-contraction coupling and fibre-type composition in aging mammals is currently under investigation. Systemic overexpression of human IGF-1 cDNA in transgenic mice resulted in IGF-1 overexpression in a broad range of visceral organs and increased concentrations of IGF-1 in serum (Mathews et al ., 1988) . These transgenic mice exhibited an increase in body weight and organomegaly, but only a modest improvement in muscle mass. Because of the possible confounding effects of systemic expression, Coleman et al . (1995) targeted IGF-1 overexpression specifically to striated muscle using a myogenic expression vector containing regulatory elements from both the 5 ′ -and 3 ′ -flanking regions of the avian skeletal α -actin gene. IGF-1 overexpression in cultured muscle cells causes precocious alignment and fusion of myoblasts into terminally differentiated myotubes and elevated the levels of myogenic basic helix-loop-helix factors, intermediate filament and contractile protein mRNA (Coleman et al ., 1995) . Transgenic mice carrying a single copy of the hybrid skeletal α -actin/hIGF-I transgene had hIGF-I mRNA levels that were approximately half those of the endogenous murine skeletal α -actin gene on a per allele basis, while conferring substantial tissue-specific overexpression without elevating serum levels of IGF-1. Importantly, this localized, muscle-specific overexpression of human IGF-1 caused significant hypertrophy of myofibres, suggesting that IGF-1 is a more potent myogenic stimulus when derived from a sustained autocrine/paracrine release than when exogenously administrated. Similar hypertrophy has been observed in response to simple intramuscular injections of IGF-1 in adult rats (Adams & McCue, 1998) .
Effects of IGF-1 on muscle in aging animals have also been investigated; in old mice, muscle-specific overexpression of IGF-1 leads to preservation of skeletal muscle force and DHPR expression (Renganathan et al ., 1998; Musaro et al ., 2001) , while viral-mediated muscle-specific expression of IGF-1 prevents age-related loss of type-IIB fibres (Barton-Davis et al ., 1998) . There is evidence that the capacity of IGF-1 to induce muscle hypertrophy declines in adult and senescent mice (Chakravarthy et al ., 2001) . However, its effects on fibre-specific force is sustained until late ages (González & Delbono, 2001c) , suggesting that the pathways evoked by IGF-1 to control fibre size and force-generating capacity diverge. Overexpression of the mIGF-1 isoform, corresponding to the human IGF-1Ea gene, resulted in sustained mouse muscle hypertrophy and regenerative capacity throughout life (Musaro et al ., 2001) indicating that this muscle-specific splice variant of the IGF-1 gene has a different role in muscle molecular composition and function than the other IGF-1 splice variants (see below).
IGF-1 in excitation-contraction coupling in skeletal muscle
Preliminary evidence suggests that one of the mechanisms by which IGF-1 may affect functional interactions between nerve and muscle is through regulation of transcription of the DHPR α 1S gene. Although the DHPR α 1 subunit plays a key process in excitation-contraction coupling, basic mechanisms regulating DHPR α 1S gene expression are unknown. To understand the regulatory elements that control transcription L-type Ca 2+ channel/DHPR α 1S we isolated and sequenced the 1.2-kb 5 ′ -flanking region fragment immediately upstream of the mouse DHPR α 1S gene (Zheng et al ., 2002) . Luciferase reporter constructs driven by different promoter regions of mouse DHPR α 1S gene were used for transient transfection assays in muscle C2C12 cells. In these preparations we found that three regions corresponding to CREB, GATA-2 and SOX-5 consensus sequence within the 5 ′ -flanking region of the DHPR α 1S gene are important for DHPR α 1S gene transcription. Antisense oligonucleotides against CREB, GATA-2 and SOX-5 significantly reduced charge movement in C2C12 cells (Zheng et al ., 2002) . This study demonstrated that the transcription factors CREB, GATA-2 and SOX-5 play a significant role in the expression of the skeletal muscle DHPR/ L-type Ca 2+ channel α 1S .
Whether IGF-1 regulates these transcription factors and subsequently the expression of the DHPR α 1S gene is not known. Using a similar approach to that described previously (Zheng et al ., 2002) , we therefore investigated the effects of IGF-1 on various promoter deletion-luciferase reporter constructs. These constructs were transfected into C2C12 cells and IGF-I effects were measured by recording luciferase activity. IGF-I significantly enhanced DHPR α 1S transcription in those constructs carrying the CREB binding site but not in CREB core binding site mutants. Gel mobility shift assay using a double stranded oligonucleotide for the CREB site in the promoter region, and competition experiments with excess unlabelled or mutated promoter oligonucleotide, and unlabelled consensus CREB oligonucleotide indicate that IGF-1 induces CREB binding to the DHPR α 1S promoter. IGF-1-mediated enhancement in charge movement was prevented by incubating the cells with antisense but not with sense oligonucleotides against CREB. These preliminary results support the conclusion that IGF-1 regulates DHPR α 1S transcription in muscle cells by acting on the CREB element of the promoter (Zheng et al ., 2001) (Fig. 1) . Therefore, it will be important to confirm these results in skeletal muscle and to determine whether IGF-1 -CREB signalling is preserved in aging mammals as well as the signalling pathway linking IGF-1R to CREB activation. As far as we understand these effects, they are mediated by the direct action of IGF-1 on muscle cells, perhaps via the activation of satellite cells (Barton-Davis et al., 1998) . However, IGF-1 also has effects on neurones which may or may not involve neuronal access to muscle-derived IGF-1.
Effects of IGF-1 on neurones
The role of IGF-1 in motor neurone survival has been examined during embryonic or postnatal life (Neff et al., 1993) as well as in spinal cord pathology (Rind & von Bartheld, 2002) . For example, in young rodents IGF-1 expression is up-regulated in Schwann cells and astrocytes following spinal cord and peripheral nerve injury, while IGF-binding protein 6 is strongly upregulated in injured motorneurones (Hammarberg et al., 1998 Interestingly, in regions of muscle enriched with neuromuscular junctions, IGF-II exhibited prominent up-regulation in satellite and possibly glial cells during recovery from sciatic nerve crush (Pu et al., 1999) while IGF-I showed less significant changes. In young animals, systemic administration of IGF-1 decreases lesion-induced motor neurone cell death and promotes muscle re-innervation (Vergani et al., 1998) . IGF-1 also promotes neurogenesis and synaptogenesis in diverse areas of the central nervous system such as the hypocampal dentate gyrus during postnatal development (O'Kusky et al., 2000) or increases proliferation of granule cell progenitors (Ye et al., 1996) . These studies suggest that IGF-1 might have beneficial effects on spinal cord motor neurones from senescent mammals. However, a number of questions remain to be answered. Are the beneficial effects of IGF-1 retained in the adult and aged organism? Are effects regulated by transcription of the hormone or by the receptor? What are the differences between the effects of IGF-I and IGF-II? Are the effects of IGF-I on neurones mediated by paracrine secretion from associated target or non-neuronal cells?
Answers to some of these questions are available. For example, in the CNS during embryonic as well as postnatal development, specific sets of neurones show high levels of IGF type-I receptor gene expression combined with IGF-1 expression in the same neurones, while in other (hippocampal and cortical) neurones, receptor and IGF-1 expression are localized in different cell groups (Bondy et al., 1992) . These patterns of expression suggest that IGF-1 exerts autocrine as well as paracrine effects in the CNS, in addition to its previously described paracrine (muscle-derived) actions on spinal cord motor neurones. These mechanisms undoubtedly contribute to the development of appropriate neuronal phenotype in early life and probably also to its maintenance in adulthood. The involvement of IGFs in neuronal aging processes remains substantially untested. However, despite these reservations, it can be hypothesized that an age-related decline in neuronal, as well as muscle-derived, IGF-1, combined with altered IGF-1-resistance through reduced expression or sensitivity of the type-1 IGF receptor, may contribute to the atrophy or death of motor and other CNS neurones in aging mammals. In their turn, these changes may, through the mechanisms previously described, trigger a cascade of events leading to decreases in skeletal muscle gene transcription (Fig. 1 ).
Conclusions and future direction
We have argued for the importance of neural factors in agerelated impairments of mammalian skeletal muscle structure and function. As predicted by classical neurotrophic theory, decrease in local production of IGF-1 and/ or neurotrophins, in addition to tissue resistance to these factors through altered receptor expression or responsiveness, may result in loss and atrophy of spinal cord motor neurones. However, declining motor neurone function may precede, and be more extensive than, that predicted by structural assays. In addition, evidence is discussed that impairment in motor neurone function may lead to reduced synthesis of muscle-derived IGF-1, and hence, via a vicious circle of effects, to neurodegeneration. Preliminary data are described suggesting that reduced synthesis of IGF-1 may contribute to decreased CREB phosphorylation via the possible failure of an IGF-mediated pathway. In its turn, reduced CREB phosphorylation may result in reduced DHPRα 1S transcription with consequent excitation-contraction uncoupling and decreased muscle force (Fig. 1) . IGF-1 may also be produced by neurones and glial in different regions of the nervous system, showing that IGF-1 may have autocrine or paracrine (neuroneto-neurone; glia-to-neurone) effects within the nervous system, as well as paracrine (neurone-to-muscle; muscle-to-neurone) effects at the neuromuscular junction. Given this complexity, it is scarcely surprising that the role of neurally mediated trophic interactions in the age-related decline of skeletal muscle function is not fully understood. We hypothesize that neural factors (autocrine trophic factors, nerve activity and connectivity) play a vital role in preventing age-related excitation-contraction uncoupling. Based on this hypothesis, we predict that interventions aimed at counteracting nerve loss will play an important part in ameliorating the loss of force exhibited in animal models of aging as well as in elderly humans.
